Abstract
The intraoperative, immediate postoperative, and late postoperative morbility and prostate-specific antigen (PSA) levels in 511 consecutive patients with clinical T1b, T1c, and T2 tumors, who underwent anatomical radical retropubic prostatectomy, have been discussed. Between 1988 and 1995, prostatic cancer was diagnosed in 511 patients on the basis of PSA and prostate biopsy, when life expectancy was more than 10 years and frozen sections of obturator lymph nodes were negative. All specimens were cut into 3 mm sections by the step-section technique, after the surgical margin had been inked with formalin-resistant dye to identify the margin status. The mean age of the 511 patients was 63.4 years. Blood loss during the operation decreased to 986 ml in the last 2 years. Of the patients, 4.3% had intraoperative rectal perforation; only 5 required a second operation, which was done with a simple rectal approach. Ureteral injury occurred in 1.4% and this was repaired during the operation; 11% had prolonged lymphocele; all were treated conservatively. Deep-venous thromboses were seen in 3.7%; 5 patients (1%) had pulmonary embolism, which was lethal in 3 patients (0.6% of the whole group). There were no intraoperative deaths. No patient death was observed in the last 3 years, when all lymphoceles were diagnosed with thorough ultrasonographic evaluation and drained immediately. Complete continence after 1 year was achieved in 92% of the patients; 5.8% of the patients had anastomotic stricture; most were treated with a single calibration. Twelve months after the operation, 80% of the patients had no measurable PSA. There was a clear correlation of PSA negativity to tumor stage. Anatomical radical prostatectomy is safe and can cure about 70% of patients with clinical T1b,T1c, and T2 prostatic tumors.
Similar content being viewed by others
References
Borland RN, Walsh PC (1992) The management of rectal injury during radical retropubics prostatectomy. J. Urol 147:905–907
Catalona WJ, Basler JW (1993) Return of erections and urinary continence following nerve sparing radical retropubic prostatectomy. J Urol 150:905–907
Geary ES, Dendinger TE, Freiha FS, Stamey TA (1995) Nerve sparing radical prostatectomy: a different view. J Urol 154:145–149
Gibbson RP, Correa RJ Jr, Brannen GE, Weisman RM (1989) Total prostatectomy for clinically localized prostatic cancer: long-term results. J Urol 141:564–566
Hammerer P, Huland H (1994) Systematic sextant biopsies in 651 patients referred for prostate evaluation. J Urol 151:99–102
Hautmann RE, Sauter TW, Wenderoth UK (1994) Radical retropubic prostatectomy: morbidity and urinary continence in 418 consecutive cases. Urology 43 [Suppl]:47–51
Huland H (1991) Morphologische Grundlagen zur radikalen Prostatektomie. Urologe A 30:361–369
Johansson JE, Adami HO, Andersson SO, Bergstrom R, Holmberg L, Krusemo OB (1992) High 10-years survival rate in patients with early, untreated prostatic cancer. JAMA 267:2191–2196
Leandri P, Rossignol G, Gautier JR, Ramon J (1992) Radical retropubic prostatectomy: morbidity and quality of life. Experience with 620 consecutive cases. J Urol 147:883–887
Lepor H, Kimball AW, Walsh PC (1989) Cause-specific actuarial survival analysis: a useful method for reporting survival data in men with clinically localized carcinoma of the prostate. J Urol 141:82–84
McNeal JE, Villers AA, Redwine EA, Freiha FS, Stamey TA (1990) Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate. Cancer 66:1225–1233
Noldus J, Huland H (1994) Therapie der erektilen Dysfunktion nach radikaler Prostatektomie. Fertilität 10:110–113
Noldus J, Huland H (1995) Dyeing: a simple method for detecting positive or negative surgical margins. Urology 45:133–135
Noldus J, Gonnermann D, Huland H (1995) Autologous blood transfusion in radical prostatectomy: results in 263 patients. Eur Urol 27:213–217
O'Donnel PD, Finan BF (1989) Continence following nerve-sparing radical prostatectomy. J Urol 142:1227–1229
Ohori M, Wheeler TM, Kattan MW, Goto Y, Scardino PT (1995) Prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol 154:1818–1824
Papsidero LD, Wang MC, Valenzuela LA, Murphy GP, Chu TM (1980) A prostate antigen in sera of prostatic cancer patients. Cancer Res 40:2428–2432
Partin AW, Pound CR, Clemens JQ, Epstein JI, Walsh PC (1993) Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years. Urol Clin North Am 20:713–725
Reiner TA, Walsh PC (1979) An anatomical approach to the surgical management of the dorsal vein and Santorini's plexus during radical retropubic surgery. J Urol 121:198–200
Schmid HP, McNeal JE, Stamey TA (1993) Observation on the doubling time of prostate cancer. The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume. Cancer 71:2031–2040
Stamey TA, McNeal JE, Freiha F, Redwine E (1988) Morphometric and clinical studies on 68 consecutive radical prostatectomies. J Urol 139:1235–1239
Villers A, McNeal JE, Freiha FS, Baccon-Giod L, Stamey TA (1993) Invasion of Denonvilliers fascia in radical prostatectomy specimens. J Urol 149:793–798
Zincke H, Oesterling JE, Blute ML, Bergstrahl EJ, Myers RP, Barrett DM (1994) Long-term (15 years) results after radical prostatectomy for clinically localized (state T2c or lower) prostate cancer. J Urol 152:1850–1857
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Noldus, J., Hammerer, P., Graefen, M. et al. Surgical therapy for localized prostatic carcinoma. J Cancer Res Clin Oncol 123, 180–184 (1997). https://doi.org/10.1007/BF01214671
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01214671